Global Fund to Fight AIDS, Tuberculosis and Malaria Debate

Full Debate: Read Full Debate
Department: Department for International Development

Global Fund to Fight AIDS, Tuberculosis and Malaria

Baroness Hayman Excerpts
Thursday 12th December 2013

(10 years, 6 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness Hayman Portrait Baroness Hayman (CB)
- Hansard - -

My Lords, it is a real pleasure for me to be able to congratulate the noble Lord, Lord Verjee, on what I think all noble Lords would agree was an outstanding maiden speech. It was passionate, very personal and very modest. The noble Lord’s story is an extraordinary one of academic, entrepreneurial and philanthropic success. His business achievements are manifold, but anyone who has ever fought an election campaign will always owe him a particular debt of gratitude as the founder of Domino’s Pizza in the UK.

In his speech, the noble Lord referred to what aid money can achieve when well spent. The noble Lord, Lord Verjee, is not only a generous but an intelligent philanthropist. He works, through the Rumi Foundation, in a variety of fields, but I pay particular tribute to the work that he has described today in encouraging, through the leadership programme, people from underrepresented groups to participate in political life. We hear and see a great deal about the perpetuation of privilege in public life in this country and it is enormously important that stories about those who overcome obstacles and the triumph of talent are also told as examples to others. I first heard about the noble Lord, Lord Verjee, from my son, who works in the philanthropic field. He said, “You should meet Rumi, Mum, he’s one of the really good guys”. I think that the House will share that opinion as time goes by.

None Portrait Noble Lords
- Hansard -

Hear, hear.

Baroness Hayman Portrait Baroness Hayman
- Hansard - -

When speaking about the Global Fund, I must declare my non-financial interests. I am a trustee of the Sabin Vaccine Institute, a vice-chair of the All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases and a trustee of the Malaria Consortium. I pay tribute to what the fund has achieved in the battle against malaria, to which the noble Lord, Lord Verjee, referred. Hearing the statistic that since 2001 the number of child deaths from malaria has been halved reminds you what aid money well spent can achieve. The Global Fund has been enormously important in that. The Malaria Consortium is the leading UK implementer of Global Fund money. In Uganda, with the fund’s support, we are working with the Ministry of Health to distribute more than 20 million long-lasting insecticidal nets to achieve universal net coverage in that country.

As many have said in debates about the Global Fund, it is essential that we replenish the fund if we are successfully to continue and build on what has already been done. The fund is hugely important, not only in its own work but—as was made clear to me at a meeting of the all-party group last night—in the effect it has on the upstream work to face the new challenges and create the new vaccines, medicines, insecticides and diagnostics. While those are being developed, there must be the encouragement of knowing that there will be an implementation machine to take them to the patients. It is tremendously important that the fund is replenished.

Replenishment will also allow the Global Fund to build and extend its work. I very much welcome the new funding model, which seeks to align investments in combating HIV, TB and malaria with national health strategies, while strengthening health systems and serving as a platform promoting the health of a person rather than combating only specific diseases. I feel this particularly strongly when I look at the issues of maternal and child health and of neglected tropical diseases.

For the world’s poorest people, these things do not fit into nicely delineated silos and different funding streams; these are the health issues of the poor. To be effective, we need to combine the programmes to ensure that the synergies are achieved and the best value for money is obtained. I think of it most particularly with regard to schistosomiasis. Schistosomiasis increases by twofold or threefold the likelihood that an adolescent girl exposed to HIV will contract HIV. The treatment for schistosomiasis is very cheap but, as a neglected tropical disease, it does not fall within the bounds of the Global Fund. My question to the Minister is: what are the Government willing to do to encourage the Global Fund to take a broader approach to health in the future?